Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Apr 27;33(30):3439–3446. doi: 10.1200/JCO.2014.58.8335

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2015 by American Society of Clinical Oncology

PMC Copyright notice

Fig 2. — Survival curves in observation arm according to three predominant patterns (lepidic [LEP], acinar [ACN]/papillary [PAP], and micropapillary [MIP]/solid [SOL; n = 293]) for (A) overall (OS), (B) disease-free (DFS), and (C) specific disease-free survival (SDFS). P values from log-rank test. Hazard ratios (HRs), estimated through univariable Cox model stratified on trial, were as follows: ACN plus PAP/LEP: HR, 0.76 (95% CI, 0.32 to 1.80) and MIP plus SOL/LEP: HR, 1.12 (95% CI, 0.48 to 2.62) for OS; ACN plus PAP/LEP: HR, 0.99 (95% CI, 0.43 to 2.31) and MIP plus SOL/LEP: HR, 1.60 (95% CI, 0.69 to 3.68) for DFS; and ACN plus PAP/LEP: HR, 0.89 (95% CI, 0.38 to 2.08) and MIP plus SOL/LEP: HR, 1.47 (95% CI, 0.64 to 3.40) for SDFS.